Search research articles
Contact Us
Filters
Showing results (441-450 of 537) with videos related to
Page
of 54
Sort By:
Urologic Oncology
|
December 17, 2013
Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy
Gregory R Pond, Giuseppe Di Lorenzo, Andrea Necchi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 21, 2019
Metabolomic stability of exercise-induced sweat
Sean W Harshman, Rhonda L Pitsch, Nicole M Schaeublin, et al.
The Lancet. Oncology
|
August 11, 2012
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study
Lauren C Harshman, Wanling Xie, Georg A Bjarnason, et al.
Nature Genetics
|
December 27, 2011
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Sergey I Nikolaev, Donata Rimoldi, Christian Iseli, et al.
Journal of Breath Research
|
November 9, 2019
Characterization of standardized breath sampling for off-line field use
Sean W Harshman, Rhonda L Pitsch, Christina N Davidson, et al.
Systematic Biology
|
April 4, 2017
Why Do Phylogenomic Data Sets Yield Conflicting Trees? Data Type Influences the Avian Tree of Life more than Taxon Sampling
Sushma Reddy, Rebecca T Kimball, Akanksha Pandey, et al.
Journal of Proteomics
|
January 18, 2016
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers
Sean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Talanta
|
December 11, 2020
Rate normalization for sweat metabolomics biomarker discovery
Sean W Harshman, Kraig E Strayer, Christina N Davidson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 30, 2020
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma
Bradley A McGregor, Aly-Khan A Lalani, Wanling Xie, et al.
Journal for Immunotherapy of Cancer
|
February 19, 2020
Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
Sarah Abou Alaiwi, Wanling Xie, Amin H Nassar, et al.
Page
of 54
Search research articles
Search
Showing results (441-450 of 537) with videos related to
Sort By:
Page
of 54
Urologic Oncology
|
December 17, 2013
Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy
Gregory R Pond, Giuseppe Di Lorenzo, Andrea Necchi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 21, 2019
Metabolomic stability of exercise-induced sweat
Sean W Harshman, Rhonda L Pitsch, Nicole M Schaeublin, et al.
The Lancet. Oncology
|
August 11, 2012
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study
Lauren C Harshman, Wanling Xie, Georg A Bjarnason, et al.
Nature Genetics
|
December 27, 2011
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Sergey I Nikolaev, Donata Rimoldi, Christian Iseli, et al.
Journal of Breath Research
|
November 9, 2019
Characterization of standardized breath sampling for off-line field use
Sean W Harshman, Rhonda L Pitsch, Christina N Davidson, et al.
Systematic Biology
|
April 4, 2017
Why Do Phylogenomic Data Sets Yield Conflicting Trees? Data Type Influences the Avian Tree of Life more than Taxon Sampling
Sushma Reddy, Rebecca T Kimball, Akanksha Pandey, et al.
Journal of Proteomics
|
January 18, 2016
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers
Sean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Talanta
|
December 11, 2020
Rate normalization for sweat metabolomics biomarker discovery
Sean W Harshman, Kraig E Strayer, Christina N Davidson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 30, 2020
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma
Bradley A McGregor, Aly-Khan A Lalani, Wanling Xie, et al.
Journal for Immunotherapy of Cancer
|
February 19, 2020
Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
Sarah Abou Alaiwi, Wanling Xie, Amin H Nassar, et al.
Page
of 54